Prospectively Predict the Efficacy of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy
NCT04993378
·
clinicaltrials.gov ↗
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Advanced Gastric Adenocarcinoma
Immunotherapy
Interventions
DEVICE:
EV-array
Sponsor
Shen Lin